FDA Approves World's First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. MU
2. SPY
3. SPCX
4. APTX:CN
5. IQMX
6. EROC
7. MSTR
8. RIVN
9. TSLA
10. MSFT

Go back to FDA Approves World's First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States
(NYSE: SENS) Delayed: 6.26 --0 (-0%)
Previous Close $6.26    52 Week High $4.24 
Open $6.26    52 Week Low $2.17 
Day High $6.26    P/E N/A 
Day Low $6.26    EPS $0.00 
Volume 455,585